High prevalence of diabetes, strong annual growth in number of type 2 diabetes patients, advancement in medical technology, and rising awareness about diabetes are the prime factors driving the global diabetes treatment devices market. With advancement in medical technology, the diabetes treatment devices are becoming smart, portable and affordable. The advent of different type of insulin pens such as decomposable insulin pens and insulin patch pens has helped the patients in effectively monitoring the blood glucose levels and in administering appropriate or prescribed levels of insulin. Additionally, the manufacturers of diabetes treatment devices are focusing on product innovation to incorporate advanced functionalities such as data recording, analytics, and smart reminders to sustain the intense competition in the market. Though the market is consolidated, the competition among the leading players is becoming intense. The global diabetes treatment devices market is expected to witness significant growth during the forecast period dynamically evolving market landscape.
North America contributed the largest share to the global diabetes treatment devices market in 2019 and is anticipated to be a dominating geography during the forecast period. The United States contributed the largest share owing to increasing prevalence of diabetes, presence of leading manufacturer, and adoption of advanced diabetes treatment product. Asia Pacific is anticipated to be the fastest growing market during the forecast period owing to increasing number of type 2 diabetic patients. Increasing awareness regarding diabetes, growing adoption of insulin delivery devices fueled by advancement in medical technology and expansion of medical device manufacturing industry, expansion of healthcare infrastructure across major countries, and expanding population to contribute towards the growth of Asia Pacific diabetes treatment devices market during the forecast period.
The report titled “Diabetes Treatment Devices Market - Global Market Share, Trends, Analysis and Forecasts, 2023-2032” wherein 2021 is historic period, 2032 is the base year, and 2023 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global diabetes treatment devices market. Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market. For instance, Abbott Laboratories reported revenues of USD 31.9 billion in 2019 and the product segment analysis of the company indicates that Medical Devices business segment of the company dominated revenue in 2019.
The global diabetes treatment devices market is segmented based on product type, sales channel, end user, and geography. Based on product type, the global diabetes treatment devices market is segmented into blood glucose monitoring devices, and insulin delivery devices. The blood glucose monitoring devices are sub-segmented into continuous glucose monitoring devices, and self-monitoring devices (blood glucose meters, testing strips, and lancets). The insulin delivery devices are sub-segmented into pumps, pens, syringes, and jet injectors. Based on sales channel, the global diabetes treatment devices market is segmented into hospital pharmacies, retail pharmacies, diabetes clinics, online pharmacies, and others. Based on end user, the global diabetes treatment devices market is segmented into hospitals, homecare, and diagnostic centers. Based on geography, the global diabetes treatment devices market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America.
The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment, and would identify the segment of the company focusing on diabetes treatment devices. Further, market share of prominent companies in the global diabetes treatment devices market would also be estimated. For instance, Abbott Laboratories operates through four business segments namely Established Pharmaceutical Products, Nutritionals, Diagnostics, and Medical Devices. The diabetes treatment devices are delivered under Medical Devices business segment of the company with revenue contribution of US$ 12,239 million in 2019 and US$ 2,524 million from Diabetes Care devices.
The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, SWOT analysis, and research and development focus of all the diabetes treatment device manufacturers. The global diabetes treatment devices market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution. Product portfolio would focus on all the products under the diabetes treatment devices business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global diabetes treatment devices market.
Major players active in the global diabetes treatment devices market include Abbott Laboratories, Arkray, Inc., B Braun Melsungen AG, Bayer AG, Companion Medical, Dexcom Inc., F.Hoffmann-La-Ltd., Insulet Corporation, Lifescan, Inc., Medtronic plc, Novo Nordisk, Sanofi, Valeritas Holding Inc., and Ypsomed Holdings.
Market Segmentation:
By Device Type
By Distribution Channel
By End Use
By Geography:
High prevalence of diabetes, strong annual growth in number of type 2 diabetes patients, advancement in medical technology, and rising awareness about diabetes are the prime factors driving the global diabetes treatment devices market.
North America contributed the largest share to the global diabetes treatment devices market in 2019 and is anticipated to be a dominating geography during the forecast period.
The end-use segments in diabetes treatment devices market are hospitals, homecare, and diagnostic centers.
Key diabetes treatment devices market players are Abbott Laboratories, Arkray, Inc., B Braun Melsungen AG, Bayer AG, Companion Medical, Dexcom Inc., F.Hoffmann-La-Ltd., Insulet Corporation, Lifescan, Inc., Medtronic plc, Novo Nordisk, Sanofi, Valeritas Holding Inc., and Ypsomed Holdings.
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved